HSA Adverse Drug Reaction News 2023 Dec, Vol.25 No.3

HSA Adverse Drug Reaction News 2023 Dec, Vol.25 No.3

The aim of the news bulletin is to increase the awareness of adverse events related to health products amongst healthcare professionals, and to promote adverse event reporting related to health products.

• ADR_News_Dec2023_Vol25_No3 [PDF, 2.2 MB]

This issue includes the following topics:

• Isotretinoin and risk of psychiatric disorders and sexual dysfunction

• Severe cutaneous adverse reaction reports with modafinil and armodafinil

• AE Case in Focus 1: Test Yourself – What could have caused the rash in this patient?

• AE Case in Focus 2: Test Yourself – What was the likely cause of the musculoskeletal symptoms in this patient? What treatment options were available for his hyperlipidaemia?

• HSA participated in WHO-UMC #MedSafetyWeek 2023 global social media campaign on adverse event reporting